RAYMOND JAMES & ASSOCIATES - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 51 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$27,000
-34.1%
10,2550.0%0.00%
Q2 2021$41,000
-16.3%
10,2550.0%0.00%
Q1 2021$49,000
-57.4%
10,255
-36.9%
0.00%
Q4 2020$115,000
-70.1%
16,264
-55.4%
0.00%
Q3 2020$384,000
+152.6%
36,467
+111.8%
0.00%
Q2 2020$152,000
+280.0%
17,218
+57.7%
0.00%
Q1 2020$40,000
-7.0%
10,9180.0%0.00%
Q4 2019$43,000
-6.5%
10,918
-11.0%
0.00%
Q3 2019$46,00012,2680.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 837,898$1,734,0000.84%
Green Alpha Advisors, LLC 78,159$162,0000.11%
Values First Advisors, Inc. 49,485$102,0000.06%
SHELTON CAPITAL MANAGEMENT 128,532$266,0000.01%
Archford Capital Strategies, LLC 13,091$29,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$347,0000.01%
Halpern Financial, Inc. 5,800$12,0060.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$145,0000.00%
TOWNSQUARE CAPITAL LLC 23,938$50,0000.00%
Newbridge Financial Services Group, Inc. 1,200$2,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders